,i  #aai? ,,congress  #a/ ,session  ,h4 
,r4 #cdic  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,may #ai1 #bjbe ,mr4  
,khanna 7= himself1 ,mrs4 ,luna1 ,ms4   
,kaptur1 & ,mr4 ,biggs ( ,arizona7      
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,en]gy & ,comm]ce1 & 9 
addition to ! ,committees on ,ways &    
,means1 & ! ,judici>y1 = a p]iod to be  
subsequ5tly det]m9$ by ! ,speak]1 9 ea* 
case = consid]ation ( su* provisions z  
fall )9 ! jurisdiction ( ! committee    
conc]n$  ,a ,,bill  ,to r$uce           
prescription drug prices by align+      
,u4,s4 prices ) int]national b5*m>ks4   
#a4 ,%ort title ,?is ,act may be cit$ z 
! ,global ,fairness 9 ,drug ,pric+ ,act4
  #b4 ,drug pric+  7a7 ,mo/-favor$      
nation price t>gets ,n lat] ?an #cj days
 aft] ! date ( enactm5t ( ?is ,act1 !   
,secret>y ( ,heal? & ,human ,s]vices    
%all1 9 coord9ation ) ! ,adm9i/rator ( !
 ,c5t]s = ,m$ic>e  ,m$icaid ,s]vices &  
o!r heads ( relevant ,f$]al             
ag5cies--propose a rulemak+ plan to     

impose mo/-favor$-nation price t>gets to
 ph>maceutical manufactur]s to ensure t 
prices = ph>maceutical products paid by 
pati5ts 9 ! ,unit$ ,/ates are comp>able 
to ! prices = su* products paid by      
comp>ably develop$ c\ntries4  7b7       
,importation by individuals ,! ,secret>y
 ( ,heal? & ,human ,s]vices %all c]tify 
to ,congress t importation "u section   
#hjd7;j7 ( ! ,f$]al ,food1 ,drug1 &     
,cosmetic ,act 7#ba ,u4,s4,c4 #chd7;j77 
w pose no risk to ! heal? & safety ( !  
public & w result 9 a significant       
r$uction 9 ! co/ ( prescription drugs to
 ! ,am]ican pati5ts 9 ! ,unit$ ,/ates2 &
 ! ,secret>y ( ,heal? & ,human ,s]vices 
%all take action "u section             
#hjd7;j77#b77;,b7 ( su* ,act to describe
 circum/ances "u :i* waiv]s w be        
consi/5tly grant$ to individuals to     
import prescription drugs1 on a         
case-by-case basis1 f develop$ c\ntries 
) l[-co/ prescription drugs4  7c7       
,en=cem5t actions ,! ,attorney ,g5]al & 
! ,*air ( ! ,f$]al ,trade ,commission   

%all1 to ! ext5t consi/5t ) law1        
und]take en=cem5t action aga9/ any      
anticompetitive practices by            
ph>maceutical manufactur]s1 includ+     
?r\gh en=cem5t ( sections #a & #b ( !   
,%]man ,act 7#ae ,u4,s4,c4 #a1 #b7 &    
section #e ( ! ,f$]al ,trade ,commission
 ,act 7#ae ,u4,s4,c4 #de71 z            
appropriate4  7d7 ,programs enabl+      
direct-to-,consum] pur*ases ,to ! ext5t 
p]mitt$ by law1 ! ,secret>y ( ,heal? &  
,human ,s]vices %all facilitate         
direct-to-consum] pur*as+ programs =    
ph>maceutical manufactur]s t sell _!    
ph>maceutical products to pati5ts 9 !   
,unit$ ,/ates at ! prices det]m9$ ?r\gh 
! rulemak+ "u subsection 7a74  7e7 ,/udy
 ( unreasonable or discrim9atory        
behaviors ( manufactur]s ,! ,secret>y ( 
,comm]ce & ! ,unit$ ,/ates ,trade       
,repres5tative %all conduct a /udy to   
det]m9e :e!r any act1 policy1 or        
practice by ph>maceutical manufactur]s  
con/itutes unreasonable or discrim9atory
 behavior t--  7#a7 impairs national    

security2  7#b7 =ces pati5ts 9 ! ,unit$ 
,/ates to subsidize global ph>maceutical
 rese>* & developm5t2 or  7#c7 involves 
suppression ( drug prices 9 =eign m>kets
 bel[ fair m>ket value4  ,! f9d+s ( su* 
a /udy %all be submitt$ 9 a report to   
,congress n lat] ?an #ahj days aft] !   
date ( ! enactm5t ( ?is ,act4